Avantor Q4 revenue beats expectations on currency impact

Avantor

11/02/2026 11:12

Overview

Life science tools firm's Q4 revenue decreased 1% but beat analyst expectations

Adjusted EPS for Q4 met analyst expectations

Company is implementing Revival program, including VWR brand relaunch and e-commerce upgrades

Outlook

Company is focusing on top-line growth and strategic investments in 2026

Avantor aims to create sustainable shareholder value through strategic initiatives

Revival program includes relaunch of VWR brand and e-commerce upgrades

Result Drivers

REVIVAL PROGRAM - Avantor is executing a Revival program to improve agility and customer focus, including VWR brand relaunch and e-commerce upgrades

FOREIGN CURRENCY IMPACT - Foreign currency translation positively impacted sales, offsetting some of the organic decline

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Sales
Beat
$1.66 bln
$1.64 bln (16 Analysts)
Q4 Adjusted EPS
Meet
$0.22
$0.22 (18 Analysts)
Q4 Net Income
$52.40 mln
Q4 Gross Profit
$523.90 mln
Q4 Operating Income
$126.40 mln
Q4 Pretax Profit
$80.80 mln


Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 15 "hold" and 2 "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

Wall Street's median 12-month price target for Avantor Inc is $12.05, about 8% above its February 10 closing price of $11.16

The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 13 three months ago

Press Release: ID:nPn1Mz9V5a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)